Home > Insider Trading > Vir Biotechnology Inc.

Vir Biotechnology Inc. (VIR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2024 Earnings Call Transcript

Operator: Hello. Welcome to Vir Biotechnology’s Fourth Quarter and Full Year 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Keep Reading →

February 27th, 2025 - News Transcripts

Why These 15 Stocks Are Skyrocketing in 2025

The market has started to favor smaller companies in 2025, and stocks between $1 billion and $5 billion in market value are attracting renewed interest.

Keep Reading →

January 22nd, 2025 - News

Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript

Operator: [Call starts abruptly] …Vir's Third Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Keep Reading →

November 2nd, 2024 - News Transcripts

Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2024 Earnings Call Transcript

Operator: Hello. Welcome to Vir Biotechnology’s Second Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Keep Reading →

August 3rd, 2024 - News Transcripts

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript

Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Keep Reading →

May 3rd, 2024 - News Transcripts

Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript

Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc.

Keep Reading →

February 23rd, 2024 - News Transcripts

Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript

Operator: Hello, and welcome to Vir Biotechnology's Third Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Keep Reading →

November 4th, 2023 - News Transcripts

10 Oversold Healthcare Stocks to Buy

In this article, we will take a look at the 10 healthcare stocks to buy.

Keep Reading →

August 12th, 2023 - Hedge Funds Lists

Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2023 Earnings Call Transcript

Operator: Hello. Welcome to Vir Biotechnology Second Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Keep Reading →

August 4th, 2023 - News Transcripts

5 Oversold NASDAQ Stocks to Buy

San Francisco, California-based Vir Biotechnology, Inc. (NASDAQ:VIR) is a commercial-stage immunology company focused on the development of therapies to treat and prevent serious infectious diseases.

Keep Reading →

August 1st, 2023 - Hedge Funds Lists